Nanosilver particles are present in consumer and health care products. Their effects on human microsomal cytochrome P450 (P450) activities and induction in luciferase reporter-engineered Caco-2 (MDR1.C) and HepG2 (DPX2 and 1A2DRE) cells have been investigated. The LD 50 values were ϳ4 g silver/ml for HepG2 and 5 g/ml for Caco-2 cells. At silver concentrations that showed no decreased cell viability (<1 g silver/ml), the pregnane X receptor (PXR)-driven 4.5-fold induction response of MDR1.C cells to 50 M omeprazole was unaffected. In DPX2 cells, the PXR-driven 5.5-and 6.5-fold induction responses to omeprazole and 10 M rifampicin were attenuated to 4-and 3.5-fold, respectively. Nanosilver particles alone showed no induction. In 1A2DRE cells, the aryl hydrocarbon receptor-driven 5.5-fold induction response to omeprazole was attenuated to 4-fold. In 1A2DRE cells, nanosilver alone elicited slight induction at 1 g/ml. The inhibition of human P450-selective activities by nanosilver particles in vitro was proportional to the silver/microsomal protein ratio. At a fixed (0.5 mg/ml) protein concentration, P450-selective activities differed in sensitivity (IC 50 value). 
Introduction
Silver has long been known to be a potent antimicrobial agent. In recent years, silver, much of it in nanoparticle form, has also been used in items such as children's toys, baby bottles, textiles, cleaning agents, refrigerators, dishwashers, washing machines, air conditioners, air purifiers, and vacuum cleaners. There are also a variety of nanosilver-containing dermatological preparations and cosmetics available, which are promoted for their antibacterial properties. Solutions containing 5-to 15-nm (mean size, 10 nm) nanosilver particles comprising an interior of elemental silver and an exterior of ionic silver oxide are commercially available as mineral supplements and are promoted for immune support. The recommended adult dosage for one such product, the one used in this study, is 150 g of silver taken orally three times per day. Information on the biodistribution of ingested nanosilver particles and concentrations reached within the human body is not known. Orally ingested nanosilver particles first affect cells in the gastrointestinal tract and are therefore the first potential source of drug-drug interactions. If the particles enter the circulation from the intestine, the next cells affected are those of the liver. In experimental animals, mice fed 13-nm silver nanoparticles showed signs of inflammation in the liver, indicating that the intestine is indeed a portal of entry for this size nanosilver particle (Cha et al., 2008) . Mice fed 30-nm silica particles showed evidence of liver toxicity, indicating that it is also a portal of entry for nonmetallic nanoparticles (So et al., 2008) . Organically modified 20-nm silica particles conjugated with a fluorophore in mice (Kumar et al., 2010) and 20-nm gold nanoparticles in rats (Balasubramanian et al., 2010) were both predominantly localized to the liver within 1 day after intravenous injection. Studies with galactose-PEGylated nanoparticles showed that after tail vein injection, 50-nm particles accessed hepatocytes specifically, whereas larger 140-nm particles deposited in the Kupffer cells (Popielarski et al., 2005) . Large silver nanoparticles (56 nm) given to rats at doses of 30, 125, and 500 mg/kg by gavage for 90 days resulted in dose-dependent accumulation of silver in the liver of 4 to 69 g/g (males) and 9 to 99 g/g (females) (Kim et al., 2010) .
The effects of nanosilver particles on intestine and liver cells are therefore important to investigate because these are the tissues that are exposed to high concentrations of nanoparticles and also the major locations of enzymes and transporters that affect the disposition of a wide range of drugs and other xenobiotics. Changes in, and effects on, these enzymes and transporters are often important sources of unanticipated drug-drug interactions. In this study, the effect of nanosilver particles on commercially available luciferase reporter-engineered (human epithelial colorectal adenocarcinoma) Caco-2 (MDR1.C) and (human hepatocellular carcinoma) HepG2 (DPX2 and 1A2DRE) cells in culture and their ability to respond to xenobiotic inducing agents have been investigated. Studies have shown that 10-nm silver nanoparticles gain access to all subcellular compartments of HepG2 cells Article, publication date, and citation information can be found at http://dmd.aspetjournals.org. doi:10.1124/dmd.110.035238.
in culture (Kim et al., 2009) , so contact with drug-metabolizing enzymes localized in the endoplasmic reticulum is to be expected in vivo. Therefore, the direct effects of nanosilver particles on human microsomal cytochrome P450 (P450) activities in vitro have also been evaluated. Reports on P450 induction and inhibition by silver particles, or nanoparticles of any description, are scarce. With respect to induction, fish exposed to 10-nm silver particles have shown induction of CYP1A2 in their gill tissue (Scown et al., 2010) . Rats injected with 20-nm gold nanoparticles have shown induction of CYP1A1 mRNA after 2 months (Balasubramanian et al., 2010) . With respect to inhibition, silver nanoparticles (15 nm) showed similar inhibition (95-98% at 50 ppm) of activities of human CYP1A2, CYP2C19, and CYP3A4 expressed in insect cell membrane preparations. Expressed CYP2C9 was slightly less inhibited (84%) (Sereemaspun et al., 2008) . Nonmetallic carboxyl polystyrene particles (20 -60 nm) inhibited the enzymatic activity of several P450 enzymes (CYP3A4, CYP2D6, and CYP2C9) in both insect cell membrane preparations and liver microsomes (Fröhlich et al., 2010) , suggesting that "inert" nanoparticles in and of themselves can produce unexpected effects on liver cell function. The present study sought to evaluate whether nanosilver particles also have the potential to affect important liver cell functions such as detoxification and elimination of drugs and, therefore, could be a potential source of unanticipated drug-drug interactions in the human population.
Materials and Methods
The nanosilver solution was obtained from American Biotech Labs (Alpine, UT) as a 30-ppm solution in distilled water. Luciferase reporter-engineered Caco-2 (MDR1.C) and HepG2 (DPX2 and 1A2DRE) cells were obtained from Puracyp, Inc (Carlsbad, CA) and maintained in the cell-appropriate media purchased from Puracyp, Inc. Cell viability and luciferase activity were determined using a MultiTox-Fluor Multiplex Cytotoxicity Assay and a Bright-Glo Luciferase Assay System, respectively (Promega, Madison, WI). Nanosilver toxicity (LD 50 ) values were obtained after 24 h of exposure. Induction by rifampicin and omeprazole was determined 24 h after the addition of the inducer; for nanosilver effects on induction, the cells had been pre-exposed to nanosilver in the medium for 24 h. Experiments were repeated on several batches of cells. The results reported are the mean Ϯ S.E.M. of quadruplicate determinations on a single batch. Interbatch induction responses were within 25% of each other. The fold induction was in comparison to vehicle dimethyl sulfoxide (DMSO)-treated controls. Statistical analyses of cell viability and induction responses were undertaken using analysis of variance, and differences, considered significant at p Ͻ 0.05, were assessed by Fisher's partial least squares difference multiple range test. Human liver microsomes were purchased from Human Biologics International Inc. (Scottsdale, AZ), Celsis International Ltd. (Chicago, IL), and Puracyp Inc. Cytochrome P450 monooxygenase activities toward 7-methoxyresorufin, coumarin, 7-ethoxy-4-trifluoromethylcoumarin, 7-methoxy-4-(aminomethyl)-coumarin, and benzyloxyquinoline were determined in kinetic assays from the rates of fluorescence increase arising from the formation of the hydroxyl-containing metabolites. Monooxygenase activities toward diclofenac, S-mephenytoin, chlorzoxazone, and testosterone were determined by high-performance liquid chromatography analysis of the microsomal incubation extract and quantified by integration of peak areas. All microsomal assays were performed at 37°C in the presence of excess NADPH. Reported IC 50 values were the means of three independent determinations, each with duplicates at each data point. Assay details and original references on P450 selectivity were reported previously (Franklin and Constance, 2007) , with two exceptions. Assay details and P450 selectivity for 7-methoxy-4-(aminomethyl)-coumarin demethylation and 7-benzyloxyquinoline debenzylation were reported by Onderwater et al. (1999) and Stresser et al. (2002) , respectively. The P450 substrates, metabolites, high-performance liquid chromatography internal standards, NADPH, and cytochrome c were purchased from Sigma-Aldrich (St. Louis, MO), with the exception of 7-methoxy-4-(aminomethyl)-coumarin, 7-hydroxy-4-(aminomethyl)-coumarin, benzyloxyquinoline, and hydroxyquinoline (BD Biosciences, San Jose, CA) and S-mephenytoin, 4-hydroxymephenytoin, and 6-hydroxychlorzoxazone (SAFC Corp., St. Louis, MO).
Throughout this article, nanosilver particle concentrations are given as total silver concentrations. For cell-based results, silver concentrations are given in micrograms per milliliter; for describing effects on enzyme activities, concentrations are given in micromolars to fit most readily with existing literature on the subject.
Results
For both luciferase reporter-engineered HepG2 cell lines (DPX2 and 1A2DRE) in culture, the LD 50 determined after 24 h of exposure to the nanosilver particles in the medium was ϳ4 g silver/ml (Table 1) . For reporter-engineered Caco-2 cells (MDR1.C), the LD 50 was ϳ5 g silver/ml. For the cell medium, we investigated the effect of nanosilver on the induction response to drugs at silver concentrations of 0.1 to 1.0 g/ml. At 1 g silver/ml, none of the three cell lines showed a significant decrease in cell viability (Table 1 ). In cells that were exposed to the nanosilver 24 h before the addition of inducing agent, the 24-h, pregnane X receptor (PXR)-driven, 4.5-fold induction response of MDR1.C cells to 50 M omeprazole was unaffected (Fig. 1) . In the absence of drugs, nanosilver particles did not elicit any induction. In HepG2 cells, however, the presence of silver depressed the induction response. In DPX2 cells, the PXR-driven 5.5-fold induction response to 50 M omeprazole was attenuated to a 4-fold response and seemed to be largely independent of the silver concentration for the range investigated (Fig. 2) . The PXR-driven induction by 10 M rifampicin was attenuated to a much greater extent, from 6.5-to ϳ3.5-fold (Fig. 2) . In 1A2DRE cells, the aryl hydrocarbon receptor (AhR)-driven 5.5-fold induction response to 50 M omeprazole was attenuated to a 4-fold response (Fig. 3) , and again the attenuation was largely independent of the silver concentration. In 1A2DRE cells, nanosilver particles at 1 g silver/ml (9.3 M) showed a slight induction response.
Nanosilver inhibition of all human microsomal P450-selective activities was proportional to the silver/protein ratio. Examples shown are for the inhibition of testosterone 6␤-hydroxylation, a reaction with a relatively low IC 50 value (Fig. 4, top) , chlorzoxazone 6-hydroxylation (Fig. 4, middle) , and 7-ethoxy-4-trifluoromethylcoumarin Odeethylation (Fig. 4, bottom) , reactions with intermediate and relatively high IC 50 values, respectively. When a battery of P450-selective reactions was examined at a fixed protein concentration (0.5 mg protein/ml) and near-K m substrate concentrations, the activities showed differences in sensitivity to inhibition by nanosilver (Table 2) . S-Mephenytoin 4-hydroxylation exhibited the lowest (6.4 Ϯ 0.1 M) and coumarin 7-hydroxylation and 7-ethoxy-4-trifluoromethylcoumarin O-deethylation exhibited the highest IC 50 values (33.5 Ϯ 2.3 and 31.9 Ϯ 2.5 mM, respectively). Other IC 50 values were, in ascending order, 8.0 Ϯ 0.3, 8.8 Ϯ 0.5, and 9.3 Ϯ 0.2 M (testosterone 6␤-hydroxylation, 7-benzyloxyquinoline debenzylation, and diclofenac 4-hydroxylation, respectively), 16.0 Ϯ 1.4 M (chlorzoxazone 6-hydroxylation), 21.2 Ϯ 1.3 M ([7-methoxy-4-(aminomethyl)-coumarin] O-demethylation), and 24.4 Ϯ 1.1 M (7-methoxyresorufin Odemethylation). As anticipated from the protein dependence of the degree of inhibition, the mechanism of inhibition was noncompetitive. From a four substrate concentration/six inhibitor concentration evaluation, the nanosilver K i value for testosterone 6␤-hydroxylation was 6.6 M. Human liver microsomal NADPH cytochrome c reductase activity in the various microsomes used in the P450-selective activity determinations was inhibited less than 12% at 70 M silver (Table 3) , a concentration in excess of the IC 50 values for monooxygenase reactions.
Discussion
Silver nanoparticles are far from biologically inert and have significant effects on drug-metabolizing enzymes systems in vitro. They are toxic to both Caco-2 (human epithelial colorectal adenocarcinoma) and HepG2 (human hepatocellular carcinoma) cells in culture, with 50% decreases in viability occurring at approximately 4 to 5 g/ml (37-47 M) with 24 h of exposure (Table 1) . In this study, the toxicity values obtained for reporter-engineered HepG2 cells using the live/dead cell protease activity as a monitor are considerably higher than the 0.5 to 3.4 g/ml IC 50 values reported for cytotoxicity for HepG2 cells after 28-h exposure to 10-nm nanosilver particles (Kim et al., 2009 ). The 0.5 to 3.4 range arose from the three different cytotoxicity tests: lactate dehydrogenase leakage, Alamar Blue reduction, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction. The mechanism of toxicity was concluded to be via oxidative stress (Kim et al., 2009 ), a mechanism that had been reported earlier for 15-and 100-nm silver particles in rat liver-derived BRL 3A cells (Hussain et al., 2005) .
The ability of nanosilver particles to affect the induction response of colon-and liver-derived cells to drugs was conducted at concentrations at and below 1 g/ml, concentrations where no decrease in cell viability was apparent. In addition to affecting induction by the drugs omeprazole and rifampicin, it was of interest to determine whether nanosilver particles themselves are able to elicit induction either through the PXR/PXR response element (DPX2 and MDR1.C cells) or through the AhR/xenobiotic response element (1A2DRE cells) mechanisms. At 1 g/ml (9.3 M), nanosilver particles caused a small (1.8-fold) induction in 1A2DRE cells (Fig. 3) , an observation perhaps consistent with a reported effect of gold nanoparticle treatment in rats inducing CYP1A1 (Balasubramanian et al., 2010) . Although competition for the AhR might explain the attenuation of induction elicited by omeprazole by nanosilver particles at 1 g/ml, it would not explain the equally large attenuation of omeprazole induction at lower nanosilver concentrations that did not show induction (0.1 g/ml). The similarity of the nanosilver attenuation of omeprazole induction in both 1A2DRE and DPX2 cells (Figs. 3 and 2 , respectively) could suggest some sequestering of the drug by nanosilver particles to prevent omeprazole from interacting with receptors. If dmd.aspetjournals.org this sequestering was the case, however, a dose response would be expected, with ever increasing attenuation with increasing nanosilver concentrations, but this activity was not seen. In fact, in DPX2 cells, there is less attenuation at the highest (1 g/ml) nanosilver concentration. In addition, there was no attenuation of omeprazole induction in MDR1.C cells (Fig. 1) , which would have been anticipated if the "effective" concentration of omeprazole were lowered by sequestration with nanosilver particles. Both omeprazole and rifampicin can induce via the PXR/PXR response element mechanism present in these cells (Yueh et al., 2005) , but the attenuation of induction in the same DPX2 cell line is much greater with rifampicin as the inducer than with omeprazole (Fig. 2) . In whatever manner nanosilver is attenuating induction, it seems that omeprazole is better able to override the block. A peculiar feature of the attenuation is the ϳ0.1 g/ml (ϳ1 M) threshold phenomenon, which is apparent with both inducers and in all cell lines (Figs. 1-3 ). Higher nanosilver concentrations (7-10-fold) produce little or no change in the attenuation. The lower limit of this threshold and the range over which attenuation is dose-dependent have yet to be explored, but our current interpretation is that nanosilver affects one of many components that control the extent of induction over the time frame investigated (24 h), and the other components continue to allow induction but at a reduced rate or to a reduced extent. The possibility of a second mechanism of unanticipated drug-drug interactions and altered drug disposition in vivo arises from the inhibition of microsomal P450-catalyzed oxidations. When substrates that are preferentially metabolized by different forms of P450 are used, it is apparent that CYP2C9, CYP2C19, and CYP3A4 activities are most sensitive to inhibition by nanosilver (Table 2) . Together, these three P450s are responsible for the metabolism of approximately Human liver microsomes, with relatively high activity for the P450-selective substrate Human Biologics International #501 and #227 for testosterone and chlorzoxazone, respectively, and Celsis #M008085-JTA for 7-ethoxy-4-trifluoromethylcoumarin] were incubated at three or four protein concentrations with a range of nanosilver concentrations, and the monooxygenase activity relative to activity in the absence of nanosilver was expressed as a percentage. Data points are the means of three independent determinations, each of which was a mean derived from duplicate incubations. 60% of the drugs in current use that undergo oxidative metabolism. CYP1A2, CYP2A6, and CYP2B6 activities are least subject to inhibition, and CYP2D6 and CYP2E1 activities fall into an intermediate range. Using heterologously expressed human P450s in insect cell membranes, Sereemaspun et al. (2008) found CYP2C9 to be less sensitive to 15-nm silver nanoparticle inhibition than CYP1A2, CYP2C19, and CYP3A4. Because the size of the nanosilver particles far exceeds the dimensions of even the largest substrate pockets of P450s (Ekroos and Sjögren, 2006; Otyepka et al., 2007; Ohkura et al., 2009) , the particle inhibition appears to be at a surface site. A noncompetitive best-fit mechanism for the inhibition determined for testosterone 6␤-hydroxylation supports this interpretation. Although physical disruption of the electron supply to support the P450 oxidation cannot be totally eliminated as a possibility, the insensitivity of the P450 reductase to inhibition (albeit using cytochrome c as the artificial acceptor), with less than 10% inhibition at silver concentrations 2-to 10-fold greater than concentrations causing 50% inhibition of the P450 oxidation reactions, indicates that electron flow through the flavoprotein itself is not the locus of silver inhibition. Physical disruption from particles interacting at surface sites would be supported as a mechanism from observations with small (20 -60 nm), nonmetallic, carboxyl polystyrene particles, which also inhibited the enzymatic activity of CYP3A4, CYP2D6, and CYP2C9 in insect cell preparations and normal liver microsomes (Fröhlich et al., 2010) . With these nonmetallic particles, CYP1A2 was much less susceptible to inhibition than the other P450s, as was the case in this study for nanosilver particles.
This study provides documentation of the ability of nanosilver particles to affect cell function as it relates to the metabolism and elimination of drugs and other xenobiotics. The most sensitive process affected, in terms of the nanosilver concentration at which it occurs, seems to be the ability of the cells to up-regulate P450s, a response regarded as a protective mechanism to promote metabolism and excretion when the cell is challenged with high or continuous levels of drugs and other xenobiotics. At higher concentrations, the inhibition of P450 enzyme activity is a process that is affected. It appears that not all P450s are affected equally, because IC 50 values of model reactions range from ϳ6 to 34 M. It is interesting to note that the P450 responsible for the largest proportion of drugs that undergo P450-dependent metabolism, CYP3A4, is among the enzymes with the lowest IC 50 values. Thus, ingested nanosilver particles, depending on the amount ingested and the amount that reaches the liver, can be anticipated to be a potentially frequent source of drug-drug interactions in vivo and the practice of regular ingestion regarded with some caution.
